Literature DB >> 29093108

Frequency and Mechanisms of Spontaneous Fosfomycin Nonsusceptibility Observed upon Disk Diffusion Testing of Escherichia coli.

Aaron E Lucas1, Ryota Ito1,2, Mustapha M Mustapha1, Christi L McElheny1, Roberta T Mettus1, Sarah L Bowler1, Serena F Kantz1, Marissa P Pacey1, A William Pasculle3, Vaughn S Cooper4,5, Yohei Doi6,2,5.   

Abstract

Fosfomycin maintains activity against most Escherichia coli clinical isolates, but the growth of E. coli colonies within the zone of inhibition around the fosfomycin disk is occasionally observed upon susceptibility testing. We aimed to estimate the frequency of such nonsusceptible inner colony mutants and identify the underlying resistance mechanisms. Disk diffusion testing of fosfomycin was performed on 649 multidrug-resistant E. coli clinical isolates collected between 2011 and 2015. For those producing inner colonies inside the susceptible range, the parental strains and their representative inner colony mutants were subjected to MIC testing, whole-genome sequencing, reverse transcription-quantitative PCR (qRT-PCR), and carbohydrate utilization studies. Of the 649 E. coli clinical isolates, 5 (0.8%) consistently produced nonsusceptible inner colonies. Whole-genome sequencing revealed the deletion of uhpT encoding hexose-6-phosphate antiporter in 4 of the E. coli inner colony mutants, while the remaining mutant contained a nonsense mutation in uhpA The expression of uhpT was absent in the mutant strains with uhpT deletion and was not inducible in the strain with the uhpA mutation, unlike in its parental strain. All 5 inner colony mutants had reduced growth on minimal medium supplemented with glucose-6-phosphate. In conclusion, fosfomycin-nonsusceptible inner colony mutants can occur due to the loss of function or induction of UhpT but are rare among multidrug-resistant E. coli clinical strains. Considering that these mutants carry high biological costs, we suggest that fosfomycin susceptibility of strains that generate inner colony mutants can be interpreted on the basis of the zone of inhibition without accounting for the inner colonies.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  disk diffusion; fosfomycin; mechanism of resistance; susceptibility testing

Mesh:

Substances:

Year:  2017        PMID: 29093108      PMCID: PMC5744208          DOI: 10.1128/JCM.01368-17

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  33 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Prevalence of fosfomycin resistance among CTX-M-producing Escherichia coli clinical isolates in Japan and identification of novel plasmid-mediated fosfomycin-modifying enzymes.

Authors:  Jun-ichi Wachino; Kunikazu Yamane; Satowa Suzuki; Kouji Kimura; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2010-04-19       Impact factor: 5.191

Review 3.  International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases.

Authors:  Kalpana Gupta; Thomas M Hooton; Kurt G Naber; Björn Wullt; Richard Colgan; Loren G Miller; Gregory J Moran; Lindsay E Nicolle; Raul Raz; Anthony J Schaeffer; David E Soper
Journal:  Clin Infect Dis       Date:  2011-03-01       Impact factor: 9.079

4.  Prokka: rapid prokaryotic genome annotation.

Authors:  Torsten Seemann
Journal:  Bioinformatics       Date:  2014-03-18       Impact factor: 6.937

Review 5.  Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens.

Authors:  Drosos E Karageorgopoulos; Rui Wang; Xu-Hong Yu; Matthew E Falagas
Journal:  J Antimicrob Chemother       Date:  2011-11-16       Impact factor: 5.790

6.  Biological costs and mechanisms of fosfomycin resistance in Escherichia coli.

Authors:  Annika I Nilsson; Otto G Berg; Olle Aspevall; Gunnar Kahlmeter; Dan I Andersson
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

7.  Susceptibility to alternative oral antimicrobial agents in relation to sequence type ST131 status and Coresistance phenotype among recent Escherichia coli isolates from U.S. veterans.

Authors:  James R Johnson; Sarah M Drawz; Stephen Porter; Michael A Kuskowski
Journal:  Antimicrob Agents Chemother       Date:  2013-07-22       Impact factor: 5.191

8.  CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin.

Authors:  Jesús Oteo; Beatriz Orden; Verónica Bautista; Oscar Cuevas; Margarita Arroyo; Rocío Martínez-Ruiz; María Pérez-Vázquez; Marta Alcaraz; Silvia García-Cobos; José Campos
Journal:  J Antimicrob Chemother       Date:  2009-08-11       Impact factor: 5.790

9.  Characterization of Fosfomycin Resistant Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolates from Human and Pig in Taiwan.

Authors:  Sung-Pin Tseng; Sheng-Fan Wang; Cheng-Yu Kuo; Jun-Wei Huang; Wei-Chun Hung; Guan-Ming Ke; Po-Liang Lu
Journal:  PLoS One       Date:  2015-08-17       Impact factor: 3.240

Review 10.  Molecular Mechanisms and Clinical Impact of Acquired and Intrinsic Fosfomycin Resistance.

Authors:  Alfredo Castañeda-García; Jesús Blázquez; Alexandro Rodríguez-Rojas
Journal:  Antibiotics (Basel)       Date:  2013-04-16
View more
  8 in total

1.  Performance of Four Fosfomycin Susceptibility Testing Methods against an International Collection of Clinical Pseudomonas aeruginosa Isolates.

Authors:  Elizabeth C Smith; Hunter V Brigman; Jadyn C Anderson; Christopher L Emery; Tiffany E Bias; Phillip J Bergen; Cornelia B Landersdorfer; Elizabeth B Hirsch
Journal:  J Clin Microbiol       Date:  2020-09-22       Impact factor: 5.948

2.  Activity of fosfomycin and amikacin against fosfomycin-heteroresistant Escherichia coli strains in a hollow-fiber infection model.

Authors:  I Portillo-Calderón; M Ortiz-Padilla; B de Gregorio-Iaria; V Merino-Bohorquez; J Blázquez; J Rodríguez-Baño; J M Rodríguez-Martínez; A Pascual; F Docobo-Pérez
Journal:  Antimicrob Agents Chemother       Date:  2021-03-08       Impact factor: 5.191

3.  Use of Fosfomycin Etest To Determine In Vitro Susceptibility of Clinical Isolates of Enterobacterales Other than Escherichia coli, Nonfermenting Gram-Negative Bacilli, and Gram-Positive Cocci.

Authors:  James A Karlowsky; Melanie R Baxter; Alyssa R Golden; Heather J Adam; Andrew Walkty; Philippe R S Lagacé-Wiens; George G Zhanel
Journal:  J Clin Microbiol       Date:  2021-09-08       Impact factor: 5.948

4.  Susceptibility of Clinical Isolates of Escherichia coli to Fosfomycin as Measured by Four In Vitro Testing Methods.

Authors:  James A Karlowsky; Philippe R S Lagacé-Wiens; Nancy M Laing; Melanie R Baxter; Heather J Adam; George G Zhanel
Journal:  J Clin Microbiol       Date:  2020-09-22       Impact factor: 5.948

Review 5.  Mechanisms and clinical relevance of bacterial heteroresistance.

Authors:  Dan I Andersson; Hervé Nicoloff; Karin Hjort
Journal:  Nat Rev Microbiol       Date:  2019-06-24       Impact factor: 60.633

6.  The Role of fosA in Challenges with Fosfomycin Susceptibility Testing of Multispecies Klebsiella pneumoniae Carbapenemase-Producing Clinical Isolates.

Authors:  Zachary S Elliott; Katie E Barry; Heather L Cox; Nicole Stoesser; Joanne Carroll; Kasi Vegesana; Shireen Kotay; Anna E Sheppard; Alex Wailan; Derrick W Crook; Hardik Parikh; Amy J Mathers
Journal:  J Clin Microbiol       Date:  2019-09-24       Impact factor: 5.948

7.  Selection for Resistance to a Glyphosate-Containing Herbicide in Salmonella enterica Does Not Result in a Sustained Activation of the Tolerance Response or Increased Cross-Tolerance and Cross-Resistance to Clinically Important Antibiotics.

Authors:  Judith Pöppe; Katrin Bote; Abhinaya Ramesh; Jayaseelan Murugaiyan; Benno Kuropka; Michael Kühl; Paul Johnston; Uwe Roesler; Olga Makarova
Journal:  Appl Environ Microbiol       Date:  2020-11-24       Impact factor: 4.792

8.  Novel Chromosomal Mutations Responsible for Fosfomycin Resistance in Escherichia coli.

Authors:  Vincent Cattoir; Annabelle Pourbaix; Mélanie Magnan; Françoise Chau; Victoire de Lastours; Brice Felden; Bruno Fantin; François Guérin
Journal:  Front Microbiol       Date:  2020-10-20       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.